Policybazaar's Bold Healthcare Bet: Investors Unmoved by Rs 696 Crore Infusion

PB Fintech, the parent company of Policybazaar, saw its shares drop by 11% over two days after announcing a Rs 696 crore investment in its healthcare branch. The market reacted negatively despite the company's plan to enhance operations, brand awareness, and strategic initiatives.

On Thursday, shares of PB Fintech, known for its ownership of Policybazaar, plummeted by 6% following an announcement to invest Rs 696 crore into its healthcare division. This decision seemingly failed to instill confidence among investors.

Continuing a downward trend for two consecutive days, PB Fintech's stock witnessed a dip of 5.90%, closing at Rs 1,322.80 on the NSE. Similarly, it saw a 5.44% decline on the BSE, finalizing at Rs 1,327.80. By the end of trading, shares had depreciated by a total of 11% over the two sessions.

This significant capital infusion is aimed at boosting PB Healthcare's operational capabilities, but awaits approval from shareholders. The overall market sentiment was reflected in the decline of key indices, with BSE Sensex dropping by 200.85 points and NSE Nifty by 73.30 points.

(With inputs from agencies.)